The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes

Several drug delivery systems have been investigated to reduce the side effects of chemotherapy by encapsulating the therapeutic agent in a nanosized carrier until it reaches the tumor site. Many of these particles are designed to be responsive to the mechanical and thermal perturbations delivered b...

Full description

Saved in:
Bibliographic Details
Main Author: Ahmed, Salma E. (author)
Other Authors: Martins, Ana M. (author), Husseini, Ghaleb (author)
Format: article
Published: 2014
Subjects:
Online Access:http://hdl.handle.net/11073/21302
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513436265742336
author Ahmed, Salma E.
author2 Martins, Ana M.
Husseini, Ghaleb
author2_role author
author
author_facet Ahmed, Salma E.
Martins, Ana M.
Husseini, Ghaleb
author_role author
dc.creator.none.fl_str_mv Ahmed, Salma E.
Martins, Ana M.
Husseini, Ghaleb
dc.date.none.fl_str_mv 2014
2021-01-28T08:04:20Z
2021-01-28T08:04:20Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv Salma E. Ahmed, Ana M. Martins & Ghaleb A. Husseini (2015) The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes, Journal of Drug Targeting, 23:1, 16-42, DOI: 10.3109/1061186X.2014.954119
1029-2330
http://hdl.handle.net/11073/21302
10.3109/1061186X.2014.954119
dc.language.none.fl_str_mv en_US
dc.publisher.none.fl_str_mv Taylor & Francis
dc.relation.none.fl_str_mv https://doi.org/10.3109/1061186X.2014.954119
dc.subject.none.fl_str_mv Doxorubicin
NanoDeliv™
Pluronic®
Targeting
Ultrasound
Drug delivery systems
Nanocarriers
dc.title.none.fl_str_mv The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
dc.type.none.fl_str_mv Peer-Reviewed
Postprint
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Several drug delivery systems have been investigated to reduce the side effects of chemotherapy by encapsulating the therapeutic agent in a nanosized carrier until it reaches the tumor site. Many of these particles are designed to be responsive to the mechanical and thermal perturbations delivered by ultrasound. Once the nanoparticle reaches the desired location, ultrasound is applied to release the chemotherapy drug only in the vicinity of the targeted (cancer) site, thus avoiding any detrimental interaction with healthy cells in the body. Studies using liposomes and micelles have shown promising results in this area, as these nanoparticles with simple, yet effective structures, showed high efficiency as drug delivery vehicles both in vitro and in vivo. This article reviews the design and application of two novel nanosized chemotherapeutic carriers (i.e. micelles and liposomes) intended to be actuated by ultrasound.
format article
id aus_b6d19436fc97dddc2bdee9a3cc3f9c48
identifier_str_mv Salma E. Ahmed, Ana M. Martins & Ghaleb A. Husseini (2015) The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes, Journal of Drug Targeting, 23:1, 16-42, DOI: 10.3109/1061186X.2014.954119
1029-2330
10.3109/1061186X.2014.954119
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/21302
publishDate 2014
publisher.none.fl_str_mv Taylor & Francis
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling The use of ultrasound to release chemotherapeutic drugs from micelles and liposomesAhmed, Salma E.Martins, Ana M.Husseini, GhalebDoxorubicinNanoDeliv™Pluronic®TargetingUltrasoundDrug delivery systemsNanocarriersSeveral drug delivery systems have been investigated to reduce the side effects of chemotherapy by encapsulating the therapeutic agent in a nanosized carrier until it reaches the tumor site. Many of these particles are designed to be responsive to the mechanical and thermal perturbations delivered by ultrasound. Once the nanoparticle reaches the desired location, ultrasound is applied to release the chemotherapy drug only in the vicinity of the targeted (cancer) site, thus avoiding any detrimental interaction with healthy cells in the body. Studies using liposomes and micelles have shown promising results in this area, as these nanoparticles with simple, yet effective structures, showed high efficiency as drug delivery vehicles both in vitro and in vivo. This article reviews the design and application of two novel nanosized chemotherapeutic carriers (i.e. micelles and liposomes) intended to be actuated by ultrasound.Taylor & Francis2021-01-28T08:04:20Z2021-01-28T08:04:20Z2014Peer-ReviewedPostprintinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfSalma E. Ahmed, Ana M. Martins & Ghaleb A. Husseini (2015) The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes, Journal of Drug Targeting, 23:1, 16-42, DOI: 10.3109/1061186X.2014.9541191029-2330http://hdl.handle.net/11073/2130210.3109/1061186X.2014.954119en_UShttps://doi.org/10.3109/1061186X.2014.954119oai:repository.aus.edu:11073/213022024-08-22T12:05:16Z
spellingShingle The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
Ahmed, Salma E.
Doxorubicin
NanoDeliv™
Pluronic®
Targeting
Ultrasound
Drug delivery systems
Nanocarriers
status_str publishedVersion
title The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
title_full The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
title_fullStr The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
title_full_unstemmed The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
title_short The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
title_sort The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes
topic Doxorubicin
NanoDeliv™
Pluronic®
Targeting
Ultrasound
Drug delivery systems
Nanocarriers
url http://hdl.handle.net/11073/21302